Jagpreet Chhatwal, Ph.D

Senior Scientist Jagpreet Chhatwal
Assistant Professor of Radiology, Harvard Medical School
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Fax: 617-726-9414
Location: Institute for Technology Assessment
Massachusetts General Hospital
101 Merrimac St., 10th FL
Boston, MA 02114

Dr. Chhatwal recently joined the MGH Institute for Technology Assessment where he serves as a senior scientist. He is also a member of the faculty of Harvard Medical School. His research focuses on the application of operations research methods to improve clinical decision-making and inform health policies. Dr. Chhatwal is a decision scientist who leads health outcomes research projects in multiple disease areas including hepatitis C, hepatocellular carcinoma, liver transplantation, leukemia, and breast cancer.

Dr. Chhatwal's research on breast cancer diagnosis showed how operations research methods can improve biopsy decision-making after mammography exams. This work won multiple awards including a best junior faculty paper and best student paper from the Institute for Operations Research and Management Science. His research on hepatitis C modeling has made a direct impact on defining hepatitis C screening and treatment policies. His work on the cost and impact new hepatitis C treatment was featured by The Wall Street Journal, Forbes, The Washington Post and CNBC.

In addition, his research interests include advancement of decision-analytic methods used for medical decision-making. Dr. Chhatwal regularly teaches methods-oriented workshops at the annual meetings of the Society for Medical Decision Making and International Society for Pharmacoeconomics and Outcomes Research. He is also an editorial board member of Medical Decision Making.

Prior to joining the ITA, Dr. Chhatwal worked as a health economist for Merck Research Laboratories and was a faculty member at the University of Pittsburgh Graduate School of Public Health and MD Anderson Cancer Center. He received a Bachelor's Degree in Industrial Engineering from Thapar Institute of Engineering and Technology, India in 2001. He then pursued a Master's Degree in Industrial Engineering at Iowa State University in 2004, and a PhD in Industrial Engineering, focusing on operations research, at the University of Wisconsin-Madison in 2008. He won 2nd place prize in George Dantzig dissertation award, a prestigious award for the best dissertation in any area of operations research and management science that is innovative and relevant to practice.

Selected links of media coverage:

The Economic Times: http://health.economictimes.indiatimes.com/news/pharma/how-beneficial-are-generic-hepatitis-c-drugs-available-in-india/58734705
Stat News: https://www.statnews.com/pharmalot/2017/05/18/generic-hepatitis-cost-effective
WBUR: As Cancer Drugs' Prices Skyrocket, Experts Worry About Burden On Patients, Health Systems
WBUR: From The War On Cancer To The Moonshot: 'What's Different Now Is Everything'
Stat: High prices for some leukemia drugs will make them less cost-effective
Marketplace: Cutting prison hepatitis C rates: costly, but worth it?
WSJ: Hepatitis C Drugs are Cost Effective, but Affordability is Another Matter
Forbes: Critical Reports Mount On Hepatitis C Pill Costs
CNBC: Gilead's hepatitis C drugs largely cost-effective in U.S. -study
CBS News: Hepatitis C could be a rare disease in 20 years
The Washington Post: Cancer drugs aren't just really expensive; they're a bad value
The ASCO Post: Study Finds Current Prices of Hematologic Cancer Drugs Are Not Justified

 

 

Tools

Tool for Changing Cycle Lengths in State-Transition Models

Publications

  • Chen, Q., Jain, N., Ayer, T., Wierda, W. G., Flowers, C. R., O'Brien, S. M., Keating, M. J., Kantarjian, H. M. & Chhatwal, J. (2017). Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35(2), 166-174. [Online version]
  • Samur, S. K., Bethea, E., Chung, R. T. & Chhatwal, J. (2017). Cost-effectiveness of pre- vs post-liver transplant hepatitis C treatment: Robustness of results.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . [Online version]
  • He, T., Lopez-Olivo, M. A., Hur, C. & Chhatwal, J. (2017). Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6.. Alimentary pharmacology & therapeutics, . [Online version]
  • Deshmukh, A. A., Cantor, S. B., Fenwick, E., Chiao, E. Y., Nyitray, A. G., Stier, E. A., Goldstone, S. E., Wilkin, T. & Chhatwal, J. (2017). Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is now.. Vaccine, . [Online version]
  • Chhatwal, J. (2017). Hepatitis C Treatment is Cost-Saving Irrespective of the Perspective.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . [Online version]